Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Enhanced predictive validity of integrative models for refractory hyperthyroidism considering baseline and early therapy characteristics: a prospective cohort study

Fig. 6

Comparison of AUC between different logistic regression models. A Model B vs. Model A. B Model C vs. Model A. Model A: baseline predictive model for total group (N = 346). Model B: combined model of high cumulative MMI dosage group (≥ 1730 mg, average ≥ 20 mg/day, N = 114) at 3 months of therapy. Model C: combined model of medium–low cumulative MMI dosage group (< 1730 mg, average < 20 mg/day, N = 232) at 3 months of therapy

Back to article page